METHODS FOR REDUCING LIPOPROTEIN (a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

• 收藏
• 分享

专利权人:

INC.;REGENERON PHARMACEUTICALS

发明人:

SWERGOLD, GARY

申请号：

ZA201401114

公开号：

ZA201401114B

申请日:

2014.02.13

申请国别(地区):

ZA

年份:

2015

代理人:

摘要：

The present invention provides methods for reducing lipoprotein(a) (Lp(a)) in patients. The methods of the present invention comprise selecting a patient who exhibits elevated serum Lp(a), and administering to the patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/